Immuron (IMRN) Accumulated Expenses (2016 - 2025)
Immuron (IMRN) recorded quarterly Accumulated Expenses of $315639.4 in Q2 2025, down 8.35% quarter-over-quarter from $344387.1 in Q2 2024, and down 8.35% on a YoY basis from $344387.1 in Q2 2024.
Immuron (IMRN) Accumulated Expenses (2016 - 2025) Analysis & Trends
Immuron's Accumulated Expenses history runs 10 years deep, the most recent figure standing at $315639.4 for Q2 2025.
- In Q2 2025, Accumulated Expenses fell 8.35% year-over-year to $315639.4; the TTM figure through Jun 2025 stood at $315639.4 (down 8.35% YoY), while the FY2025 annual figure was $319432.5, down 6.8% from the prior year.
- Accumulated Expenses was $315639.4 for Q2 2025 at Immuron, down from $344387.1 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $344387.1 in Q2 2024 to a low of $63028.8 in Q4 2022.
- Historically, Accumulated Expenses has averaged $171485.8 across 5 years, with a median of $159988.8 in 2021.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses sank 59.58% in 2022, then jumped 181.51% in 2023.
- A 5-year view of Accumulated Expenses shows it stood at $155937.4 in 2021, then tumbled by 59.58% to $63028.8 in 2022, then jumped by 206.89% to $193428.9 in 2023, then surged by 78.04% to $344387.1 in 2024, then slipped by 8.35% to $315639.4 in 2025.
- The last three Accumulated Expenses figures came in at $315639.4 (Q2 2025), $344387.1 (Q2 2024), and $193428.9 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 315,639.43 |
| Jun 30, 2024 | 344,387.08 |
| Jun 30, 2023 | 193,428.86 |
| Dec 31, 2022 | 63,028.76 |
| Aug 31, 2022 | 66,712.61 |
| Jun 30, 2022 | 68,712.34 |
| Dec 31, 2021 | 155,937.42 |
| Jun 30, 2021 | 164,040.23 |
| Jun 30, 2020 | 138,119.41 |
| Jun 30, 2019 | 249,245.55 |
| Dec 31, 2018 | -89,391.00 |
| Sep 27, 2018 | -217,810.78 |
| Aug 30, 2018 | -297,606.00 |
| Jun 30, 2018 | 329,523.03 |
| Dec 31, 2017 | -215,518.61 |
| Sep 28, 2017 | -218,106.97 |
| Aug 31, 2017 | -276,539.00 |
| Jun 30, 2017 | 427,429.66 |
| Dec 31, 2016 | -84,787.09 |
| Jun 30, 2016 | -311,262.15 |